🎀 #PinkOctober: Can genomic testing help avoid unnecessary chemotherapy in breast cancer? Meet Betty, a participant in the MINDACT study.
Learn more: www.eortc.org/blog/2026/10...
🎥 Watch her story:
#MINDACT #EORTCbreast
Learn more: www.eortc.org/blog/2026/10...
🎥 Watch her story:
#MINDACT #EORTCbreast
October 21, 2026 at 3:24 PM
🎀 #PinkOctober: Can genomic testing help avoid unnecessary chemotherapy in breast cancer? Meet Betty, a participant in the MINDACT study.
Learn more: www.eortc.org/blog/2026/10...
🎥 Watch her story:
#MINDACT #EORTCbreast
Learn more: www.eortc.org/blog/2026/10...
🎥 Watch her story:
#MINDACT #EORTCbreast
70-gene signature MammaPrint for early-stage HR-positive, HER2-negative #BreastCancer: outcome in the MINDACT trial for key clinical-pathological high-risk subgroups. www.ejcancer.com/article/S095...
70-gene signature MammaPrint for early-stage HR-positive, HER2-negative breast cancer: outcome in the MINDACT trial for key clinical-pathological high-risk subgroups
Adjuvant chemotherapy (ACT) can be safely omitted in patients above 50 years of age
with stage I-II hormone receptor positive (HR+) HER2-negative (HER2-) breast cancer
and a low-risk 70-gene signature...
www.ejcancer.com
September 18, 2026 at 8:49 AM
70-gene signature MammaPrint for early-stage HR-positive, HER2-negative #BreastCancer: outcome in the MINDACT trial for key clinical-pathological high-risk subgroups. www.ejcancer.com/article/S095...
Back to Hall D, learning about molecular profiling in #breastcancer from @DrHBurstein, focused on early stage now with MINDACT &
TAILORx, #ASCO19
TAILORx, #ASCO19
November 18, 2024 at 5:25 PM
Back to Hall D, learning about molecular profiling in #breastcancer from @DrHBurstein, focused on early stage now with MINDACT &
TAILORx, #ASCO19
TAILORx, #ASCO19
Happy International Day of Women & Girls in Science!
At EORTC, we celebrate the women advancing cancer research. 💡
Prof Piccart helped lead MINDACT, transforming breast cancer care and reducing unnecessary chemotherapy.
Find out more: www.eortc.org/impact/
#EORTCimpact
At EORTC, we celebrate the women advancing cancer research. 💡
Prof Piccart helped lead MINDACT, transforming breast cancer care and reducing unnecessary chemotherapy.
Find out more: www.eortc.org/impact/
#EORTCimpact
February 11, 2026 at 2:45 PM
Happy International Day of Women & Girls in Science!
At EORTC, we celebrate the women advancing cancer research. 💡
Prof Piccart helped lead MINDACT, transforming breast cancer care and reducing unnecessary chemotherapy.
Find out more: www.eortc.org/impact/
#EORTCimpact
At EORTC, we celebrate the women advancing cancer research. 💡
Prof Piccart helped lead MINDACT, transforming breast cancer care and reducing unnecessary chemotherapy.
Find out more: www.eortc.org/impact/
#EORTCimpact
🎗️This World Cancer Day, we’re proud to share how the EORTC-led MINDACT study helped change breast cancer care worldwide.
Hear from patient Betty & Prof Piccart.
🔗 www.eortc.org/blog/2026/02...
A big thank you to everyone involved in this study!
#WorldCancerDay #EORTCimpact
Hear from patient Betty & Prof Piccart.
🔗 www.eortc.org/blog/2026/02...
A big thank you to everyone involved in this study!
#WorldCancerDay #EORTCimpact
February 4, 2026 at 11:06 AM
🎗️This World Cancer Day, we’re proud to share how the EORTC-led MINDACT study helped change breast cancer care worldwide.
Hear from patient Betty & Prof Piccart.
🔗 www.eortc.org/blog/2026/02...
A big thank you to everyone involved in this study!
#WorldCancerDay #EORTCimpact
Hear from patient Betty & Prof Piccart.
🔗 www.eortc.org/blog/2026/02...
A big thank you to everyone involved in this study!
#WorldCancerDay #EORTCimpact
🎗️Tomorrow is World Cancer Day.
We’ll be sharing Betty’s story, a patient whose experience with the MINDACT study shows how clinical cancer research can change lives.
🎬 Don’t miss it!
#WorldCancerDay #LeavingNoCancerPatientBehind #EORTCimpact #ClinicalTrials
We’ll be sharing Betty’s story, a patient whose experience with the MINDACT study shows how clinical cancer research can change lives.
🎬 Don’t miss it!
#WorldCancerDay #LeavingNoCancerPatientBehind #EORTCimpact #ClinicalTrials
February 3, 2026 at 9:22 AM
🎗️Tomorrow is World Cancer Day.
We’ll be sharing Betty’s story, a patient whose experience with the MINDACT study shows how clinical cancer research can change lives.
🎬 Don’t miss it!
#WorldCancerDay #LeavingNoCancerPatientBehind #EORTCimpact #ClinicalTrials
We’ll be sharing Betty’s story, a patient whose experience with the MINDACT study shows how clinical cancer research can change lives.
🎬 Don’t miss it!
#WorldCancerDay #LeavingNoCancerPatientBehind #EORTCimpact #ClinicalTrials
Practice-changing research means results that directly transform patient care.
This World Cancer Day, EORTC will highlight MINDACT, a study that has changed the standard of care for breast cancer.
📅 Stay tuned!
#WorldCancerDay #ClinicalTrials #EORTCimpact #CancerResearch #CancerSurvivor
This World Cancer Day, EORTC will highlight MINDACT, a study that has changed the standard of care for breast cancer.
📅 Stay tuned!
#WorldCancerDay #ClinicalTrials #EORTCimpact #CancerResearch #CancerSurvivor
February 2, 2026 at 1:25 PM
Practice-changing research means results that directly transform patient care.
This World Cancer Day, EORTC will highlight MINDACT, a study that has changed the standard of care for breast cancer.
📅 Stay tuned!
#WorldCancerDay #ClinicalTrials #EORTCimpact #CancerResearch #CancerSurvivor
This World Cancer Day, EORTC will highlight MINDACT, a study that has changed the standard of care for breast cancer.
📅 Stay tuned!
#WorldCancerDay #ClinicalTrials #EORTCimpact #CancerResearch #CancerSurvivor
After 3 years... All is complete...
Parallel Radio WPG + SG Presents: The Project Saga
Act 1: Lost MindAct 2: Art + PassionAct 3: C:\Unknown_\Future_>
soundcloud.com/parallelradiop… soundcloud.com/parallelradiop… soundcloud.com/parallelradiop…
Parallel Radio WPG + SG Presents: The Project Saga
Act 1: Lost MindAct 2: Art + PassionAct 3: C:\Unknown_\Future_>
soundcloud.com/parallelradiop… soundcloud.com/parallelradiop… soundcloud.com/parallelradiop…
December 2, 2024 at 7:06 AM
After 3 years... All is complete...
Parallel Radio WPG + SG Presents: The Project Saga
Act 1: Lost MindAct 2: Art + PassionAct 3: C:\Unknown_\Future_>
soundcloud.com/parallelradiop… soundcloud.com/parallelradiop… soundcloud.com/parallelradiop…
Parallel Radio WPG + SG Presents: The Project Saga
Act 1: Lost MindAct 2: Art + PassionAct 3: C:\Unknown_\Future_>
soundcloud.com/parallelradiop… soundcloud.com/parallelradiop… soundcloud.com/parallelradiop…
#breastcancer - Своевременното персонализиране на лечението на рака на гърдата води до добри резултати- www.linkedin.com/posts/lifesc... -следете @nmgenomix.bsky.social за повече новини
Survival outcomes for patients with invasive lobular cancer by MammaPrint: Results from the MINDACT phase III trial | Dimitar Georgiev
За съвременната наука ракът на гърдата отдавна не е едно заболяване, а букет от различни хистологично видове карциноми /разликите се определят със сложни и комплексни патоанатомични изследвания/, коит...
www.linkedin.com
October 17, 2025 at 4:33 AM
#breastcancer - Своевременното персонализиране на лечението на рака на гърдата води до добри резултати- www.linkedin.com/posts/lifesc... -следете @nmgenomix.bsky.social за повече новини